{
    "title": "U.S. FDA delays decision on Regeneron/Roche COVID antibody therapy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10718655/U-S-FDA-delays-decision-Regeneron-Roche-COVID-antibody-therapy.html",
    "date": "2022-04-14",
    "keywords": [
        "regeneron",
        "drug",
        "antibody",
        "use",
        "review",
        "covid19",
        "cocktail",
        "treatment",
        "emergency",
        "regencov",
        "food",
        "administration",
        "application",
        "approval",
        "drugmaker",
        "thursday",
        "decision",
        "health",
        "agency",
        "fda",
        "july",
        "casirivimab",
        "imdevimab",
        "authorization",
        "mildtomoderate",
        "therapy",
        "country",
        "prevention",
        "individual",
        "risk",
        "exposure",
        "omicron",
        "coronavirus",
        "variant",
        "roche",
        "development",
        "distribution",
        "khandekar",
        "roy",
        "bengaluru",
        "editing",
        "maju",
        "samuel",
        "syamnath"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}